MTD
US EQUITY
Health Care
Life Sciences Tools & Services
CIK: 1037646
Mettler Toledo (MTD) Quant Factor Diagnostic & Fair Value Model
Mettler Toledo (Ticker: MTD) is listed in the Health Care sector (Life Sciences Tools & Services). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$1,670.29
-0.85%
Latest Close (2026-10-23)
Market Cap: $33.47B
P/E Ratio: 36.1
Momentum Strength
3M / 12M
+24.99%
1M: +9.95%
12M: +20.91%
Quality (ROE)
Point-in-Time
+7265.04%
Trailing Return on Equity
Technical Trend
RSI 14
79.8
SMA50: $1466.21
SMA200: $1332.32
Valuation Multiplier
Trailing
36.1
Premium Multiple (> 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Premium Multiple (> 30x P/E)
MTD trades at 36.1x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 7/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1037646 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-07-31 | $1.03B | $232.90M | $450.21M | $11.55 |
| 10-Q | 2026-03-31 | 2026-07-31 | $947.13M | $169.45M | $139.79M | $8.33 |
| 10-Q | 2025-12-31 | 2026-07-31 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-07-31 | $983.22M | $202.35M | $430.81M | $9.76 |
| 10-Q | 2025-03-31 | 2026-07-31 | $883.74M | $163.59M | $194.45M | $7.81 |
| 10-K | 2025-12-31 | 2026-02-06 | $4.03B | $869.19M | $955.77M | $42.05 |
| 10-K | 2024-12-31 | 2026-02-06 | $3.87B | $863.14M | $968.35M | $40.48 |
| 10-K | 2023-12-31 | 2026-02-06 | $3.79B | $788.78M | $965.87M | $35.90 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Mettler Toledo (MTD) valuation multiples, momentum factors, and point-in-time filing conventions.
How should MTD's current valuation multiple be interpreted? ↓
MTD trades at a trailing P/E of 36.1x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are MTD's key momentum and technical factor indicators? ↓
As of the latest close, MTD shows a 1-month return of +9.95%, 3-month return of +24.99%, and 12-month return of +20.91%, with a 14-day RSI of 79.8. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for MTD? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can MTD be incorporated into systematic factor models? ↓
MTD can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.